GlobalGov › France › Award

BAXTER S.A.S won France – Antineoplastic and immunomodulating agents – AO MEDICAMENTS ANTINEOPLASIQUES ET IMMUNOMODULATEURS (Classe ATC L) - Relance de 4 from CH de Saint-Brieuc/Paimpol/Tréguier - Etablissement support du GHT d'ARMOR

CH de Saint-Brieuc/Paimpol/Tréguier - Etablissement support du GHT d'ARMOR · France government award

GlobalGov surfaces government contract awards from around the world, including the markets your competitors overlook.

$7.0M
Award Value
October 15, 2024
Award Date
Awarded
Status

Award Overview

BAXTER S.A.S was awarded France – Antineoplastic and immunomodulating agents – AO MEDICAMENTS ANTINEOPLASIQUES ET IMMUNOMODULATEURS (Classe ATC L) - Relance de 4 by CH de Saint-Brieuc/Paimpol/Tréguier - Etablissement support du GHT d'ARMOR in France, tracked by GlobalGov. The award is valued at $7.0M. It was awarded on October 15, 2024. Full award details and the issuing agency are below.

See who is winning government contracts in this market — and the open opportunities coming next. Track awards, incumbents, and recompetes worldwide. Free for 14 days, no card.

Start Free

Award Details

AwardeeBAXTER S.A.S
Awardee countryFrance
Awarding agencyCH de Saint-Brieuc/Paimpol/Tréguier - Etablissement support du GHT d'ARMOR
CountryFrance
Award value$7.0M
Award dateOctober 15, 2024
Last verifiedSeptember 2, 2026

Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.

France market overview →Browse open opportunities →

Track every France contract award and the opportunities behind them. Free for 14 days.

Get incumbent intelligence, recompete alerts, and deadline tracking for this market and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required